Search research articles
Contact Us
Filters
Showing results (131-140 of 203) with videos related to
Page
of 21
Sort By:
The British Journal of Dermatology
|
June 25, 2024
COL10A1 expression distinguishes a subset of cancer-associated fibroblasts present in the stroma of high-risk basal cell carcinoma
Mauro Esposito, Laura Yerly, Prachi Shukla, et al.
Cancer Research
|
November 5, 2015
Nrf2 Activation Promotes Keratinocyte Survival during Early Skin Carcinogenesis via Metabolic Alterations
Frank Rolfs, Marcel Huber, Andreas Kuehne, et al.
Cancer Research
|
December 28, 2017
Germinal Centers Determine the Prognostic Relevance of Tertiary Lymphoid Structures and Are Impaired by Corticosteroids in Lung Squamous Cell Carcinoma
Karīna Siliņa, Alex Soltermann, Farkhondeh Movahedian Attar, et al.
Nature Communications
|
August 21, 2021
Epigenetic control of melanoma cell invasiveness by the stem cell factor SALL4
Johanna Diener, Arianna Baggiolini, Mattias Pernebrink, et al.
Cell Reports
|
May 24, 2016
A Transcriptionally Inactive ATF2 Variant Drives Melanomagenesis
Giuseppina Claps, Yann Cheli, Tongwu Zhang, et al.
Science Immunology
|
October 22, 2021
IL-12 regulates type 3 immunity through interfollicular keratinocytes in psoriasiform inflammation
Pascale Zwicky, Florian Ingelfinger, Bruno Marcel Silva de Melo, et al.
Scientific Reports
|
July 19, 2016
Tumour hypoxia promotes melanoma growth and metastasis via High Mobility Group Box-1 and M2-like macrophages
Roman Huber, Barbara Meier, Atsushi Otsuka, et al.
Communications Biology
|
October 28, 2022
Live slow-frozen human tumor tissues viable for 2D, 3D, ex vivo cultures and single-cell RNAseq
Gaetana Restivo, Aizhan Tastanova, Zsolt Balázs, et al.
Journal for Immunotherapy of Cancer
|
June 10, 2022
Combinations of Toll-like receptor 8 agonist TL8-506 activate human tumor-derived dendritic cells
Mi He, Bhavesh Soni, Petra C Schwalie, et al.
Cancer Cell
|
March 16, 2016
Inhibiting Drivers of Non-mutational Drug Tolerance Is a Salvage Strategy for Targeted Melanoma Therapy
Michael P Smith, Holly Brunton, Emily J Rowling, et al.
Page
of 21
Search research articles
Search
Showing results (131-140 of 203) with videos related to
Sort By:
Page
of 21
The British Journal of Dermatology
|
June 25, 2024
COL10A1 expression distinguishes a subset of cancer-associated fibroblasts present in the stroma of high-risk basal cell carcinoma
Mauro Esposito, Laura Yerly, Prachi Shukla, et al.
Cancer Research
|
November 5, 2015
Nrf2 Activation Promotes Keratinocyte Survival during Early Skin Carcinogenesis via Metabolic Alterations
Frank Rolfs, Marcel Huber, Andreas Kuehne, et al.
Cancer Research
|
December 28, 2017
Germinal Centers Determine the Prognostic Relevance of Tertiary Lymphoid Structures and Are Impaired by Corticosteroids in Lung Squamous Cell Carcinoma
Karīna Siliņa, Alex Soltermann, Farkhondeh Movahedian Attar, et al.
Nature Communications
|
August 21, 2021
Epigenetic control of melanoma cell invasiveness by the stem cell factor SALL4
Johanna Diener, Arianna Baggiolini, Mattias Pernebrink, et al.
Cell Reports
|
May 24, 2016
A Transcriptionally Inactive ATF2 Variant Drives Melanomagenesis
Giuseppina Claps, Yann Cheli, Tongwu Zhang, et al.
Science Immunology
|
October 22, 2021
IL-12 regulates type 3 immunity through interfollicular keratinocytes in psoriasiform inflammation
Pascale Zwicky, Florian Ingelfinger, Bruno Marcel Silva de Melo, et al.
Scientific Reports
|
July 19, 2016
Tumour hypoxia promotes melanoma growth and metastasis via High Mobility Group Box-1 and M2-like macrophages
Roman Huber, Barbara Meier, Atsushi Otsuka, et al.
Communications Biology
|
October 28, 2022
Live slow-frozen human tumor tissues viable for 2D, 3D, ex vivo cultures and single-cell RNAseq
Gaetana Restivo, Aizhan Tastanova, Zsolt Balázs, et al.
Journal for Immunotherapy of Cancer
|
June 10, 2022
Combinations of Toll-like receptor 8 agonist TL8-506 activate human tumor-derived dendritic cells
Mi He, Bhavesh Soni, Petra C Schwalie, et al.
Cancer Cell
|
March 16, 2016
Inhibiting Drivers of Non-mutational Drug Tolerance Is a Salvage Strategy for Targeted Melanoma Therapy
Michael P Smith, Holly Brunton, Emily J Rowling, et al.
Page
of 21